Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report
Mele, A.; Sparaventi, G.; Guiducci, B.; Nicolini, G.; d'Adamo, F.; Leopardi, G.; Delfini, C.; Piccaluga, P.; Visani, G.
Haematologica 89(6 Suppl): Ecr18
2004
ISSN/ISBN: 0390-6078 PMID: 15194554 Document Number: 569177
Document emailed within 1 workday
Related Documents
Unal, S.; Cakir, M.; Kuşkonmaz, B.ş; Cetin, M.; Tuncer, A.M. 2009: Successful treatment with gemtuzumab ozogamicin monotherapy in a pediatric patient with resistant relapse of acute myeloid leukemia Turkish Journal of Pediatrics 51(1): 69-71Shimokawa, T.; Kojima, Y. 2008: Reinduction therapy with gemtuzumab ozogamicin for relapsed or refractory CD33-positive acute myelogeneous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(8): 1427-1430
Jentsch-Ullrich, K.; Pelz, A-Friederike.; Braun, H.; Koenigsmann, M.; Mohren, M.; Wieacker, P.; Franke, A. 2004: Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib Haematologica 89(5): Ecr15
Piccaluga, P.Paolo.; Martinelli, G.; Malagola, M.; Rondoni, M.; Bianchini, M.; Visani, G.; Baccarani, M. 2003: Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature Haematologica 88(8): Ecr28
Yoshikawa, H.; Sao, H.; Tahara, T.; Akao, Y.; Yoshikawa, S. 1984: A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3): 515-520
Liu, J.; Guo, R.; Jiang, Z.X. 2017: Cladribine in the treatment of TET 2(+) refractory acute myeloid leukemia: a case report Zhonghua Nei Ke Za Zhi 56(10): 769-770
Bassan, R.; Lerede, T.; Buelli, M.; Borleri, G.; Bellavita, P.; Rambaldi, A.; Barbui, T. 1998: A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia Haematologica 83(5): 422-427
Kaplan, H.G.; Appelbaum, F.R.; Cheever, M.A.; Greenberg, P.D.; Wood, T.; Fefer, A. 1982: Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine Cancer Treatment Reports 66(6): 1397-1398
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Schaison, G.; Jacquillat, C.; Lemercier, N.; Alby, N.; Weil, M.; Auclerc, M.F.; Boiron, M.; Bernard, J. 1980: Complete remission of acute leukemia for more than seven years. A report on 100 children Annales de Medecine Interne 131(2): 84-86
Hsu, H.C.; Chiu, C.F.; Tan, T.D.; Chau, W.K.; Tseng, C.S.; Ho, C.H. 1995: Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report Zhonghua Yi Xue Za Zhi 56(5): 305-311
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Del Potro, E.; Díaz Mediavilla, J.; Martínez, R.; Alvarez, A.; Krsnik, I.; Guerra, J.L.; Llorente, L.; López, J.C.; Díaz Morfa, M.; Villegas, A. 1989: Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols Medicina Clinica 92(16): 601-604
Löwenberg, B.; Abels, J.; van Bekkum, D.W.; Dzoljic, G.; Hendriks, W.D.; van der Poel, J.; Sizoo, W.; Sintnicolaas, K.; Wagemaker, G. 1983: Transplantation of autologous bone marrow in 3 patients with acute myeloid leukemia in first remission; initial experiences with a new treatment Nederlands Tijdschrift Voor Geneeskunde 127(30): 1329-1332
Odajima, H.; Iwatake, K.; Baba, M.; Ode, S.; Kawai, H.; Matsui, T. 1988: A case of complete remission following recurrent relapses 12 years after onset of acute myelocytic leukemia. Response to protocol including neocarzinostatin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(1): 167-170
Miyawaki, S.; Mizoguchi, H.; Tomonaga, M.; Kanamaru, A.; Tsukagoshi, S.; Nakamura, T.; Ohashi, Y.; Yoshida, S.; Ohno, R. 1998: A phase Ii study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(14): 2229-2242
Ma, F.S.; Gao, R.L.; Jin, J.M. 1989: Leukemic clonogenic assay and drug sensitivity test of homoharringtonine and cytarabine in acute myeloid leukemia Zhonghua Nei Ke Za Zhi 28(12): 737
Sutoh, H.; Yamauchi, T.; Gotoh, N.; Sugiyama, M.; Ueda, T. 2003: Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia Anticancer Research 23(6d): 5037-5042
Torres, A.; Martínez, F.; Gómez, P.; Fornés, G.; Rojas, R.; Herrera, C.; Gómez, J.L.; Manzanares, R.; García, J.M.; Andres, P. 1989: Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission Bone Marrow Transplantation 4(6): 609-612
Harousseau, J.L.; Pignon, B.; Cahn, J.Y. 1993: Comparison between bone marrow autograft and intensive chemotherapy as treatment for maintenance of complete remission in acute myeloblastic leukemia in the adult. GOELAM Group Nouvelle Revue Francaise d'Hematologie 35(3): 197-198